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Abstract: Bio-conjugated hydrogels merge the functionality of a synthetic network with the activity
of a biomolecule, becoming thus an interesting class of materials for a variety of biomedical
applications. This combination allows the fine tuning of their functionality and activity, whilst
retaining biocompatibility, responsivity and displaying tunable chemical and mechanical properties.
A complex scenario of molecular factors and conditions have to be taken into account to ensure
the correct functionality of the bio-hydrogel as a scaffold or a delivery system, including the polymer
backbone and biomolecule choice, polymerization conditions, architecture and biocompatibility.
In this review, we present these key factors and conditions that have to match together to ensure
the correct functionality of the bio-conjugated hydrogel. We then present recent examples of
bio-conjugated hydrogel systems paving the way for regenerative medicine applications.
Keywords: bio-conjugated hydrogels; biomolecule; polymer scaffold; regenerative medicine
1. Introduction
Regenerative medicine aims to restore damaged tissue by combining aspects of biomedical-,
tissue- and genetic engineering, chemistry, material science and drug delivery. In order to achieve this,
the cells need to be stimulated to grow and differentiate correctly by molecular signals that are generally
growth factors (GFs), small drugs, proteins and nucleotide sequences [1–3]. Since the differentiation
requires molecular cues, these need to be delivered to the cell in a sustained and continued way, whilst
supporting cell growth [4].
In the past decades, one of the most significant challenges faced in regenerative medicine, tissue
engineering and in vivo biomedical devices for tissue regeneration was related to the inability to
mimic the mechanical properties and dynamic structure of the soft tissue that needed to be repaired or
constructed [5]. Thus, research has been focusing on developing soft materials that: (i) are prone to
adapt and resist physiological conditions, satisfying strict requirements for biocompatibility, softness,
resistance to mechanical stress and general chemical versatility, (ii) provide the conditions for cell
growth, differentiation and proliferation and (iii) degrade naturally or shortly after the healing of
the damaged tissue [6,7]. These requirements can be fulfilled by hydrogels, which are cross-linked
colloidal networks fully swollen in its entire volume by water if they are based on appropriate chemical
nature of their building blocks [8]. Because of their high-water content and their flexible yet strong
structure, the mechanical properties of a hydrogel resemble the consistency of soft tissue and hence
can adapt to it, enabling their nowadays widespread use in commercial applications that range from
contact lenses to hygiene products [9].
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There is an almost never-ending list of examples of hydrogels, which have been designed and
proposed as candidates for regenerative medicine, but their high cost or complexity can sometimes leave
them behind in real life applications [10–13]. Commercially available hydrogels for tissue engineering
are scaffolds, such as Mebiol® gel and Corning ® PuraMatrix™ peptide hydrogel, which are designed
for cell growth and differentiation, and are used as external in vitro devices. Besides cell scaffolding,
hydrogels are also employed in external wound dressing, and are composed of highly hydrophilic
synthetic polymers frequently in combination with polysaccharides such as cellulose, alginates and
hyaluronic acid [14]. Although their use in wound dressing is quite popular in regenerative medicine,
the high production costs for more specific and finely designed hydrogels hinders their large-scale use
in internal tissue engineering and drug delivery; thus, they have not found their way into the market
yet [9]. Nevertheless, the examples on the market generally rely upon one synthetic or natural polymer,
and not go any further in the use of natural biomolecules to widen their functionality [9]. Generally,
a hydrogel network can be designed with any polymer, which has hydrophilic moieties, so that it is
able to entrap water within its network [15]. By choosing the polymer, such to change its physical
properties in function of an external stimulus, the hydrogel can respond to that stimulus by changing
its mechanical properties and swelling behavior [16]. There is a large variety of hydrogels that are
responsive towards light [17], pH [18], temperature changes [19], electrochemical potential [20], metal
ions [21] and magnetic fields [22], as well as a combination of them [23,24]. These hydrogels are most
commonly used in regenerative medicine due to their high biocompatibility, and tunable porosity,
as well as for selective binding and protein purification, since the polymeric chains can be designed
to have functional sites that specifically bind impurities or metals without impacting the stability of
a protein [3]. What also distinguishes hydrogels from other materials is their extraordinary high-water
content, which promotes the bioavailability of small molecules [25]. Hydrogels are also commonly
used as drug delivery systems that can deliver their cargo over time or through a burst, depending on
the target application [26]. It follows that this ability can be exploited to release a molecular signal
overtime and induce cell differentiation and growth.
Polymers alone however are frequently inert, and normally function more as a scaffold or a carrier,
as in the case of most commercial hydrogels, rather than an active material whereas pure biomolecule
based hydrogels (e.g., peptides or proteins) can be toxic and trigger immune responses, leading to
their degradation unpredicted and uncontrolled manners and lose their bioactivity [3,27,28]. Besides
this, biomolecules are expensive to produce in large amounts and their resulting hydrogels are not
only very costly but also mechanically weak [29]. In order to overcome the drawbacks of single
component hydrogels, biomolecules and polymers have been combined to prepare bio-conjugated
hydrogels [30]. These hydrogels carry both the properties of the polymers they are made of (e.g.,
hydrophilicity, inertness, or stimuli responsiveness), and the functional properties of the biomolecules
(e.g., therapeutic, reversible sensing-actuation, cell binding, cell penetrating and adhesiveness) [31].
Besides the enhanced range of functionality that derives from tethering biomolecules to the polymer
network, the cross-linked matrix of the hydrogel also provides spatial confinement, anchoring and
overall protection to the biomolecule. Biomolecules serving to promote tissue regeneration are known
as growth factors (GFs), and include proteins, DNA plasmids and non-coding RNA sequences. As
the delivery of GF is still controversial from the ethical point of view, GFs are applied to nude mouse
models that are frequently not sufficient to allow human trials [32]. Additionally, GFs have been
also used as crosslinkers, contributing to both hydrogel bioactivity and mechanical properties whilst
increasing biocompatibility. As we are focusing here on GFs, we will mention briefly other biomolecules,
including carbohydrates, due to their high compatibility and low rejection rates, while for larger classes
of molecules, including aptamers, lipids and steroidal hormones, we propose the reader excellent
reviews in the field [33–35].
Here, we aim to give an overview about bio-conjugated hydrogels in which synthetic polymers and
copolymers are combined with cell-active biomolecules with emphasis on their match as an important
step to serve for successful application in regenerative medicine (Scheme 1). While there are a significant
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number of reviews on polymers and biomolecules used in regenerative medicine, a general overview
on how to choose the polymer and the biomolecule according to the final use and the compatibility
between these two classes of materials is still missing. With the goal to illustrate the molecular factors
and conditions for an appropriate combination of polymers and biomolecules supporting the design of
efficient bio-conjugated hydrogels, we present recent examples, and indicate the pathway that has
to be taken in order to design and obtain these materials. We start with design criteria of a hydrogel
for biomedical applications, followed by production of an appropriate hydrogel of interest because
the design and synthesis of a bio-conjugated hydrogel poses a series of challenges when it comes
to the combination of the synthetic systems with the biomolecule. Therefore, the way the hydrogel
is coupled with the biomolecule, without the loss of the properties of any of the parts involved are
explained here. Finally, recent examples of DNA, protein, and peptides-conjugated hydrogels are
illustrated here to present how to design a bio-conjugated hydrogel for regenerative medicine and
other biomedical applications, and which are their advantages and limitations.
Scheme 1. Schematic presentation of bio-conjugated hydrogels based on the combination of
biomolecules (DNA, proteins, and peptides) and different polymers for regenerative medicine.
2. General Factors Influencing The Design of Hydrogels for Regenerative Medicine
Each hydrogel is characterized by a series of physical and chemical properties that need to
be specifically addressed when designing a tool for regenerative medicine. Features such as
biocompatibility, gelling, degradation, porosity and intrinsic chemical properties, all play a role
in the successful execution of the aim of the hydrogel [36]. For the choice of the polymer backbone, we
redirect the reader to these outstanding reviews, which carefully and thoroughly cover the topic [36,37].
2.1. Biocompatibility
Any material, whether it finds in vivo or in vitro application on a biological system, requires high
degrees of biocompatibility, in order to minimize cell or tissue damage. For instance, hydrogels for
tissue scaffolding must be recognized by the body as not invasive, to minimize the general inflammation
process and avoid damage to cells, surrounding tissue and fibrous encapsulation [38]. Natural polymers
such as collagen or hyaluronic acid generally meet high standards of biocompatibility and are widely
used in formulation and biomedical applications, yet lack of the freedom in tuning their chemistry
and physical properties that synthetic polymers give [39]. Most synthetic hydrogels are considered
potentially biocompatible if their chains are hydrophilic enough to host very high-water contents [36,40].
In vitro non-toxicity normally just relies on chemically nontoxic molecules and inert materials on which
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cells can proliferate without undergoing environmental stress. On the other hand, in vivo compatibility
not only requires cell adhesion and proliferation but also requires hydrogel inertness towards the cell or
tissue overtime, involves the recognition of the material as non-invasive, and demands no inflammatory
response from the body. The fast reactivity of acrylates, methacrylates and acrylamides and vinyl
monomers in both “free radical” and “living” polymerization normally ensures high yields in short
times. However, these monomers also show high toxicity in soft tissue, and the difficult removal
of these from the network can frequently hamper their use for in vivo applications [41]. For this
reason, careful removal of all the monomer has to be performed before the implantation, either
internal for tissue scaffolding or external as wound dressing device. An alternative to purification
prior implantation is instead to reduce the lifetime of the monomers within the tissue before being
polymerized. Some polymers can be also problematic upon degradation: in the case of acrylamides
such as poly(N-isopropylacrylamide) (PNIPAM), the hydrolysis of the side chain leads to the formation
of small amine compounds which are cytotoxic [42]. For this reason, in the past years a great alternative
to PNIPAM has been poly(N-vinylcaprolactam) (PVCL), which has comparable responsiveness to
temperature. Regardless of the size of the hydrogel, both macro-, micro- and nano-gels have shown to be
successfully employed in vivo. However, the higher complex chemical and biological environment that
these hydrogels must face can lead to side reactions and interactions. For instance, the immune response
towards the hydrogel must be minimized or repressed in order to avoid the damage to surrounding
tissues and to promote the activity for which the hydrogel has been designed and implanted. In vitro
tests generally involve cell viability, metabolic activity and cell proliferation, which indicate no toxicity
in simple environments. Cytotoxicity however does not necessary imply biocompatibility, which
requires immunogenicity, mutagenesis and proteomics test [43]. There is a fundamental difference
in the application of polymers for in vivo or in vitro application. Specifically, some polymers like
poly(ethylene glycol) (PEG), which are the milestone for in vitro cell culture due to their unique
hydrophilicity and inert character, makes them the perfect candidates for cell culture and scaffolding.
However, the same polymer seems to be less tolerated in vivo, since recent studies have identified
the presence of anti-PEG antibodies, which clearly lead to the material rejection and inflammation
of the surrounding tissue [44]. To further promote the biocompatibility of a polymer, frequently
the device is decorated with biomolecules like heparin, which reduces thrombogenicity. [45] Further
functionalization includes the use of albumin or RGD peptides which also promote cell adhesion
and growth factors [45]. Moreover, by adjusting their porosity and micropatterning, the surface will
increase their wettability leading to an overall higher biocompatibility level, as cells tend to recognize
the material [38].
2.2. Gelling and Mechanical Properties
The gelling of a polymer is achieved by forming permanent or reversibly covalent cross-links
between the polymeric chains or can arise by the formation of physical ones that induce a viscoelastic
character to the system [46]. Covalent macro-gels are normally obtained via photo- or thermal-initiated
polymerization and rely on classic hydrophilic cross-linkers [36]. Small hydrogels, in the size range
of 10–100 µm, are generally formed by exploiting microfluidic or molding techniques, whilst even
smaller microgels (10 nm to 1 µm) are obtained with precipitation or emulsion polymerization [47].
Generally, covalently-bound hydrogels are characterized by a predominantly elastic behavior, and
can undergo axial deformation, sustain stress and mechanical friction and corrosion, whilst they
respond badly to shear forces [48]. The Young’s modulus depends on the nature of the polymer and on
the cross-linking density, as well as on the wt% of mass content of the hydrogel. Covalent hydrogels
composed of a single network, are generally stiff and brittle: the fracture energies are low (about
10 J m−2) and so are the Young’s moduli [49,50]. Once the chains are broken and are subjected excessive
strain, the deformation becomes irreversible, and ruptures and cracks appear. Cartilage implants
require significantly higher fracture energies, and thus are based on double interpenetrating networks,
since their fracture energies and Young’s moduli are magnitudes higher [48,51]. Preformed covalent
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hydrogels are generally used for external applications or inserted via invasive surgery, exemption made
for microgels, which have a radius significantly smaller than the injection needle, and macroporous
hydrogels, which benefit from the flexibility that arises from the high volume of pores [52,53]. When
injected, macroporous hydrogels expel water from the pore cavity and regain the original shape, when
extruded from the needle by taking up fluid from the surrounding environment [54]. However, they
are problematic to adapt to the new environment as it presents an irregular shape that cannot be
filled out completely. Moreover, the safety and in vivo efficacy of these materials has to be confirmed
yet [55]. An alternative to them is to inject highly concentrated microgel solutions which, due to their
soft and fuzzy structure, can be easily injected and deformed and have proven to prolong their blood
circulation time. Since these hydrogels have a high surface area and are subjected to shear forces
in the blood, the polymer needs to be stable enough to minimize erosion. For instance, covalently
cross-linked PNIPAM resists well to erosion as it is not only covalently cross-linked, but undergoes
further self-crosslinking by proton abstraction in the tertiary H of the main chain, while the more
biocompatible PVCL is structurally not able to undergo similar self-crosslinking [56]. PVCL is thus
more sensitive to shear and tends to decompose starting from the outer corona when subjected to low
shear forces [57]. It has been recently demonstrated that even manual extrusion from a syringe leads to
the cleavage of the outer corona in PVCL microgels, making them problematic for applications that
require injections. On contrary, PNIPAM microgels subjected to low shear forces maintained their
structural integrity overtime, with shear moduli ranging from 0.221 kPa to 0.015 kPa depending on
the cross-linking density.
If the cross-linking derives from supramolecular interactions, such as hydrogen bonding,
host-guest chemistry or metal ligand interaction, the class of hydrogels is known as supramolecular
hydrogels [58,59]. Supramolecular hydrogels change their mechanical properties when subjected to
shear and are thus injectable when they display shear-thinning properties [60]. The rather labile bonds
can break more easily compared to their covalent counterparts and are therefore the sacrificial bonds
that break when shear is applied, leading to the flow of the polymer hydrogel. Since the bonding and
de-bonding of the cross-links is reversible, the hydrogel can regain its original mechanical properties
once the strain is removed [59]. On the other hand, the shape is not retained, and the hydrogel assumes
the new shape of the container in which it is molded, as if it was a liquid. The viscoelastic behavior plays
a pivotal role when the hydrogel must be injected in a tissue cavity, since it can adapt to its irregular
shape [3]. The injection of shear thinning self-healing hydrogels is preferred to the in-situ gelation
of a polymer mixture, since it prevents the dispersion of the single polymer chains or monomers
before gelation. Furthermore, countermeasures to the leakage and contamination have been taken
by diametrically switching the approach in gelling kinetics [61]. The initial idea of in-situ gelling
was to have a hydrogel that undergoes the stiffening transition extra fast when outside the needle.
In recent years, a slow but steady gelling kinetics has proven successful, easier to handle and with
reduced toxicity [62]. For example, if the covalent cross-linking derives from the reaction between
a hydrazine and an aldehyde, exchanging the aldehyde for a ketone functionality leads to a reduction
of the gelling kinetics [61]. This approach not only lowered enough the gelling to achieve injection,
but also biocompatibility and transparency is dramatically enhanced. The cross-linking between
the macromers starts already in the needle, yet it is slow enough to permit the loosely cross-linked
polymer chains to be extruded through the syringe, adapt to the cavity and finish cross-linking
without any major contamination of the surrounding tissue [63]. In recent years, self-healing materials
based on supramolecular chemistry have offered fast reversibility in their mechanical properties
and structure regeneration under mild conditions and have become an important research topic in
materials design [64]. They display excellent mechanical properties, which derive from the reversible
supramolecular network in the presence of secondary interactions that bind liquid-like building blocks
into polymers in hydrated and non-hydrated states. Hence, non-covalent bonds are the most reliable to
be applied as self-healing “smart” cross-linkers or hydrogel macromers. Several chemical approaches
have been applied using a combination of non-covalent bonds, such as hydrogen bonds [65], π-π
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stacking [66], electrostatic interactions [67], metal-ligand interactions [68], hydrophobic interactions [69],
and host-guest interactions [70].
2.3. Architecture and Shape
The architecture is a key factor influencing the hydrogel’s physical behavior, namely gelling,
responsiveness towards stimuli, as well as mechanical properties. For instance, PNIPAM can form
physical hydrogels above its lower critical solution temperature (LCST) by undergoing a coil to globule
transition, as it becomes less hydrophilic in water. This decrease in hydrophilicity leads to the formation
of hydrophobic domains, which can act as physical cross-linkers when the PNIPAM chains are above
their critical gelation concentration (CGC). However, the resulting hydrogel displays extremely poor
mechanical properties when subjected to shear or stress [71]. Since the LCST value for PNIPAM [72]
(and PVCL) is 37 ◦C [73], which is also the average body temperature, this gelation method is applied
in certain cases for in situ gelling when high elasticity and toughness are not required. Other polymers
that present biomedical relevant LCST are PNIPMAM (38 ◦C) [74], poly(N,N-diethylacrylamide)
(PDEAAM) (32–34 ◦C) [75] and poly(methyl vinyl ether) (PMVE) (37 ◦C) [76]. The mechanical
properties of hydrogels can be endowed with temperature responsiveness once a cross-linker is
introduced, and the Young’s modulus can be tuned as well by changing the cross-linking density [77].
Besides the cross-linking density and distribution, the molecular weight and flexibility of the network
forming polymer chain must be considered carefully as the inter-chain entanglements and loops
also contribute to the overall toughness or resistance of the hydrogel, in addition to the influence
on the CGC [78]. Macroscopic hydrogels do not necessarily have to be composed by linear chains
cross-linked by small fragments. Contrary, there is a plethora of examples of hydrogels that find
wide applications in the biomedical field that are composed by macromers with higher complexity
architectures [79]. Star polymers can be covalently or non-covalently linked one with each other to
form a hydrogel matrix [80]. Even though the synthesis of the hydrogel precursor requires more
effort that using a single monomer, the tendency of the arms of star polymers to align rather than to
progress in random coil prevents the formation of too high entanglements and loops. The dispersity
of macromers impacts the reproducibility of the mechanical characteristics of the gels. In fact, this
can be observed well in hydrogels composed from hyperbranched polymers and dendrimers. Whilst
hyperbranched polymers are highly disperse and the branching is random, dendrimers are highly
defined structures that are almost monodisperse macromers after purification [81]. Different batches
of macroscopic hydrogels can vary greatly when composed of hyperbranched polymers, whilst
a hydrogel derived from a dendrimer of the same chemical composition will show reproducible
and fixed characteristics [82]. Both architectures ensure a dynamic inhomogeneous structure of
the overall hydrogel [83]. The varying density of the macromer throughout its structure reflects
then the variation of local chain density of the macroscopic hydrogel. This inhomogeneity resembles
the uneven structure of the extracellular matrix and allows the cells to proliferate better, also because
of it dynamic continuously re-modelling. Moreover, the extremely high number of terminal ends also
decreases the CGC [84]. Structural complexity can not only be achieved in 3D polymers, but also in
2D, where different blocks in the same polymer express significantly different physical properties.
Block copolymers can self-assemble into nanostructures with local phase separation that can lead to
organized cross-linking, leading to hydrogel formation [85]. The most popular block copolymers are
composed of di- or triblock domains. Diblock copolymers based on a hydrophilic and a hydrophobic
domain generally lead to the gelation of sample at higher wt% concentrations compared to the triblock
counterparts [86]. This behavior is attributed mainly to the intrinsic ability of triblock copolymers to
interact both inter- and intramolecularly, leading to an increase of interactions and thus drastically
reducing the CGC [86].
For microgels, a variety of architectures has been explored and proposed for biomedical
applications, mostly as candidates for drug delivery applications that involve the survival of
the hydrogel in the blood stream, or in bone marrow regeneration [87,88]. Microgels can be isotropic
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or anisotropic in size, and can have a homopolymer, core-shell, core-shell-shell, hollow or Janus
architecture [89]. All these provide the microsystem with tunable functionalities given the chemical
properties of the different polymers. Compared to macroscopic hydrogels, microgels respond
much faster to environmental changes, namely temperature, pH, light, and so on [47]. Their faster
responsiveness is correlated with their architecture: the soft and fuzzy structure combined with their
small dimension leads to almost instant changes in local polarity, solubility and size.
2.4. Porosity and Network Density
For a series of biomedical applications, that go from tissue regeneration to drug delivery, porosity
is a parameter to regard, as it influences the diffusivity of a small molecule and the proliferation of
cells within the network [90]. Each application requires a range of pore sizes that is between 5 and
100 nm, and increasing up to 400 µm. For a hydrogel to be applied in drug delivery, the width of its
pores has to be designed as function of the size, specifically the hydrodynamic radius, of the drug
or cargo that has to be delivered [26]. Generally, small molecules such as antibiotics move freely
through the network. If the pores are larger than the cargo, the release of the cargo is dominated by
diffusion [91]. By reducing the pore size to a 1 to 1 ratio with the cargo, the cargo does not diffuse
freely through the network anymore, and its release is slowed down. This is mostly due to the longer
path that the cargo has to take when is sterically hindered by the network chains. Moreover, by
increasing the network density, some pores will be smaller, lengthening the path of the cargo. By
reducing the size of the pores to a ratio smaller than one, the cargo is entrapped within the network.
In this case, the main application of the hydrogels is the long-term storage of the cargo, which can
be released by erosion. Tissue regeneration requires porosities that allow the cells to proliferate and
diffuse through the network; thus, the pore sizes should typically be in the 100–300 µm range. These
also need to promote the growth of blood vessels and general vascularization. A certain polymer
network can be organized in different pore sizes according to the formation conditions. The final
porosity strongly depends not only polymer content and cross-linking mol% and density, but also on
the formation temperature, solvent composition and solvent exchange [92]. Moreover, the introduction
of a pore-forming agent (i.e., agarose), as in the case of a PVA hydrogel, can induce the formation of
macropores that can be used in cell scaffolding (Figure 1) [93].
Figure 1. Scanning electron microscope (SEM) micrographs of dried (a) PVA hydrogel and (b–d)
macroporous PVA hydrogels treated with (b) 2 wt% (c) 4 wt% and (d) 6 wt% of agarose as pore
formation agent [93].
Some applications also require the change in porosity either instantly or over prolonged periods. To
address these two requirements, generally degradable and responsive polymers are used in the network
design. By introducing a stimuli-responsive polymer in the network, the subsequent shrinking or
swelling due to an external stimulus drastically changes the pore size and the release kinetics [94,95].
For instance, thermo- and pH responsive microgels composed of VCL and itaconic acid (IA) would
release cytochrome c (cyt-c) in different kinetics depending on the external conditions. An increase in
temperature above the volume phase transition temperature (VPTT) of the chain network or a reduction
of the pH below the pKa would lead to an immediate collapse of the pore size, and a burst release of
the protein [95].
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2.5. Degradability
How long the polymer will retain its structural integrity overtime and its resistance towards
mechanical stress, erosion and enzymatic and oxidative stress, have to be regarded in function of
the application desired for the device composed of the polymeric material. In the cases of external
devices, generally a long-lasting material composed of aliphatic main chains and not hydrolysable
cross-links is used. The chemical stability that arises from the covalent single bonds makes polymers
made out of vinyl monomers the most popular ones. The main chain has to undergo a series of
reversible conformation changes, and last over a high number of cycles. In this case, a covalent single
or double network is preferred. When the polymer is used to build a scaffold, this should mimic as
good as possible the behavior of the extracellular matrix (ECM), by either giving space to the tissue
to grow overtime and gradually disappear from the implantation site or dynamical moving away
to make space for the growing tissue. This is achieved by relying on the lability of certain bonds
within the network. According on how the polymer network will break down into smaller segments,
a polymer is degradable or resorbable [96]. If the monomers are biocompatible and do not produce
any damage to the surrounding tissue, this is the preferred approach. However, the most popular
biodegradable polymers PLA and PLGA lead to a decrease of the tissue pH value since they produce
lactic and glycolic acid, inducing inflammation of the surrounding tissue [97]. Inflammation normally
occurs as the hydrolysis of PGA into glycolic acid has been proven to activate the classical complement
pathway, which is an immune response that involves antigen antibody systems. In fact, glycolic acid
binds immunoglobulin far more than the polymer, hence inducing the inflammatory response due to
what is commonly known as an allergic reaction [98]. To avoid or reduce the inflammatory response,
decoration of the surfaces with heparin has been proven useful. Other polymers are biodegradable,
but very few do not produce allergic response when they break down into their former monomers.
An example for this class of polymers is ethylene-vinyl acetate copolymer, which provoked mild to
no inflammation even after 3 or 4 weeks after implantation [99]. The alternative degradation method
revolves around polymeric chains that break down into large chains, yet small enough to be filtered
through the kidney system. The kinetics of degradation of a polymeric construct has to be tailored
by carefully choosing the chemistry of the main chain and cross-links [100]. Degradation in longer
chains involve the cleavage of labile bonds, that can be attacked either chemically (pH changes) or
enzymatically (esterase to cleave ester bonds). The most common labile bonds are esters, digested
either by low pH or an esterase, and disulfide bonds that can be cleaved by an addition of a reducing
agent [101]. If the main chain is not degradable, it is necessary to introduce cleavable moieties, that
breakdown overtime or ‘on demand’ by changing the physical conditions or adding an enzyme
to digest specific bonds [102]. Temperature- and pH-responsive microgels were cross-linked with
a disulfide cross-linker and could be degraded upon the addition of DDT. Degradation can also occur
via the erosion of the network by spontaneous break down of the network chains from the surface
when subjected to frequent stress. Erosion is mostly uncontrolled in materials that contain amide
or ester bonds, which can be hydrolyzed under mild conditions. However, erosion is another way
to deconstruct gradually the network from outside. This is achieved by exploiting supramolecular
cross-linking [94]. The erosion rate can be fine-tuned by changing the host-guest interaction or by
changing the amount of cross-linkers within the network.
3. Synthetic Criteria for Hydrogel Production
Carefully choosing the synthetic path to build a polymeric scaffold for biomolecules requires
retaining and enhancing the properties of the whole material. Since most complex biomolecules are
sensitive to changes in the external environment and easily undergo denaturation, the bio-conjugated
hydrogels must be engineered to accommodate and protect these delicate payloads. Considering these
key points, it will allow for both building polymeric scaffolds endowed with versatile properties and
preserving the functionality of the entrapped/attached biomolecules.
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3.1. Polymer Choice
The polymer backbone defines the stiffness, elasticity and degradation of the polymer chains.
Depending on their chemical nature, the resulting hydrogels will be biocompatible, biodegradable
or intrinsically responsive to various stimuli (Table 1). Degradable polymers containing cleavable
moieties within their backbone can reduce their molecular weight overtime, until they are shortened
to units small enough to be exerted by the body. A prominent example of degradable synthetic
polymer is PLA and its corresponding PGA, which are polyesters that undergo hydrolysis in mild
acidic conditions or can be cleaved ‘on demand’ by an esterase [103]. Such polyesters are obtained
via ring-opening polycondensation [104]. The two stereoisomers, D-lactic acid and L-lactic acid,
influence both the hydrogel mechanical properties as well as its degradation rate [105]. Degradation
of a hydrogel into the human body (T = 37 ◦C) is also dependent on the temperature in aerobic
conditions, the polymer molecular weight and crystallinity [106,107]. Thus, the careful choice of
a second comonomer enables the fine-tuning on how the polymer will degrade and how fast. Besides
its low production costs and easy biodegradability, PLA also comes from renewable feedstock [108].
However, it lacks of any kind of responsivity towards external stimuli. Similarly, PCL also degrades
with different rates according to its composition and external conditions, whilst remaining bioinert [109].
To enhance the bio-functionalization, synthetic polyesters from tailored monomers can have instead
their chemical and mechanical responsiveness tuned through monomer chemical nature. For instance,
polythioesters with a functional tertiary amine display facile functionalization and allow further
biomolecule coupling [110]. Polyesters are flexible biodegradable and resorbable polymers, and come
in hand for valves and tissue regeneration applications [111–114]. Instead, if the need of a bioinert,
stronger and tougher polymer is required, polyurethanes (PUs) are the polymers of choice. PUs are
obtained by polycondensation of polyols with n-functional isocyanates [115–120]. The hydrogels
containing biodegradable PUs generally lack elasticity, due to the high crystallinity of the chains.
Introducing a trifunctional triol to be reacted together with a bi-functional diol ensured the formation
of a material with great elasticity that resembles the ECM [121]. Changing the ratios of isocyanate and
triol allows to modify the microstructure and chemistry of the PU hydrogel. Moreover, by connecting
together different segments based on hydrophilic PEG, thermosensitive poly(propylene glycol) (PPG)
and the biodegradable and hydrophobic poly(ε-caprolactone) (PCL) via urethane bonds (Figure 2),
a biocompatible thermogelling polymer (EPC) was engineered to provide an internal tamponade effect
through surface tension and swelling counterforces for the repairment of retinal detachment [119].
During its biodegradation, the thermogel promotes the reformation over time of a vitreous-like body
mimicking the biophysical properties of natural vitreous body.
Figure 2. Schematic representation of the polymerization procedure for synthesis of a biocompatible
and biodegradable EPC copolymer [119].
If a specific response towards an environmental change is required, the use of stimuli-responsive
polymers is necessary. For example, a stimuli-responsive monomer can be blended into the comonomer
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composition of an inert polymer donning a triggered responsive character to the resulting hydrogel.
Clearly, there are ranges of comonomer compositions and ratios that have to be respected to obtain
the given responsiveness [122]. Polymers that show temperature responsiveness, be it either an LCST
or upper critical solution temperature (UCST) behavior, require a monomer loading of at least
70%. This has been observed for the most common temperature-responsive polymers, i.e., PNIPAM,
poly(N-isopropylmethacrylamide) (PNIPMAM) and PVCL.
For what concerns pH responsiveness, lower loadings can be achieved whilst maintaining
a responsiveness of the main chain. Already a 2 to 5% comonomer composition of acrylic acid (AAc)
or methacrylic acid (MAAc) leads to swelling and deswelling of the overall gel [123]. Furthermore,
a content of repeating units comprised of light-responsive moieties, as low as 1%, can change the chain
polarity and thus the polymer behavior in solution [123]. Besides the most structurally simple polymers,
like PEG, polymers that contain a functional side group come in hand for post-polymerization coupling
of biomolecules or for the formation of chemical or physical cross-links within the hydrogel network.
This approach involves the polymerization of monomers that bear a functional group that will
not be attacked or degraded during the polymerization, but can then be modified and reacted
afterwards [124,125]. Representative examples include PAAc and its analogues, polyamines and
analogues, and poly(NHS) esters. Depending on the type of functional groups attached to the polymer
backbone, the possible reactions used for hydrogel formation or biomolecule coupling involve active
esters, anhydrides, isocyanates, epoxides, Michael addition reactions, cross-coupling moieties and
click chemistry reactions (Figure 3) [52,101,124,126–128]. Besides, the functional side groups can
also form physical cross-links by hydrogen bonding as in the case of ureidopyrimidone [129] or
polyphenol-based patterns and crystallization [130]. Other approaches to prepare hydrogels involve
host-guest supramolecular interactions, where one polymeric chain is generally decorated with the host
molecule and another one with the guest(s). Relevant examples include hydrogels based on binary
complexes of cyclodextrin and adamantine [131], and the ternary complexes of cucurbit[n]urils, which
have been successfully implanted into the mice brain since they perfectly mimic the consistency and
mechanical properties of neuronal tissue [132].
Clearly, most moieties that are able to react with functional groups belonging to biomolecules,
such as an NHS group, have the main drawback to have scarce solubility in water or other
biomolecule-friendly solvents. To overcome this problem, copolymerization with a water-soluble
monomer generally allows 10 mol% loading of the functional groups within the polymeric backbone,
increasing the solubility of the otherwise insoluble reactive moiety [133]. However, the synthetic
networks that provide a base for biomolecules do not have to affect the biomolecule integrity or activity.
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Table 1. The most relevant polymers involved in preparation of hydrogels for biomedical applications.
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Figure 3. Schematics presenting several functional groups involved in hydrogel formation [128] and
attachment of biomolecules via covalent bonding.
3.2. Polymerization Conditions
In the case of macroscopic hydrogels, free radical polymerization, which does not provide
any sort of control on the chain dispersity, is still a strong tool to obtain freestanding gels with
a statistical comonomer distribution [161]. From all polymerization techniques, this one, even though
air-sensitive, is one of the most robust ones. When a precise control over the chain length dispersity
and molecular weight of a polymer are required, ‘living’ polymerizations are rather advised [162].
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However, the hydrogels prepared by ‘living’ polymerizations involving metal ions, e.g., ATRP and
ROMP, need to be purified thoroughly [163]. Alternatively, metal-free “living” polymerizations such
as RAFT, MADIX, anionic and cationic are rather recommended to ensure high molecular weights and
narrow dispersity in the block length distribution [162,164,165].
During the polymerizations in which the biomolecules are co-polymerized/encapsulated within
the hydrogel network, several key parameters, including temperature, solvent and pH, need to
be fine-tuned to ensure both polymerization and preservation of the integrity and functionality of
the biomolecule. For instance, conducting the polymerization at temperatures higher than 60 ◦C can
lead to the denaturation of proteins and other biomolecules. To overcome this problem, light-induced
radicals are exploited, which lowers the temperature required to carry out the polymerization, whereas
for UV-sensitive biomolecules there is a wide variety of light-sensitive initiators that generate radicals
at RT and longer wavelengths. Proteins or DNA are not only sensitive to temperature, but also towards
pH. Polymerization that require extreme pH values to ensure the solubility of a monomer are not
suitable for simultaneous polymer formation and biomolecule encapsulation.
The choice of the solvent in which the polymerization is carried out is also fundamental in terms of
biological toxicity and biomolecule denaturation. For most hydrophilic monomers, including AAc and
NIPAM, the polymerization can be carried out easily and with high yields in biocompatible solvents,
such as H2O or DMSO. This implies that the formation of a hydrogel can be performed simultaneously
with the encapsulation or tethering of a protein or a DNA strand. However, there is a wide range of
monomers that are not soluble in water and, in order to be copolymerized in water-soluble backbones,
other solvents must be used. Alcohols, such as EtOH or MeOH, stabilize the secondary structure of
the protein (α-helix and β-hairpin), whilst leading to “molten globule” states as it denatures its tertiary
structure. Since the biological or catalytic activity of a protein depends also on its integrity, the use of
polar solvents during the synthesis of protein-polymer hybrid hydrogels is advised only if the tertiary
structure is not relevant or when a thorough purification is carried out after the formation of hydrogels.
4. Introduction of Biomolecules within the Hydrogel Network
The design of a bio-conjugated hydrogel scaffold depends on the specific application and also it has
to be tailored to interact with the biomolecules incorporated within its structure. The entrapment and
tethering of biomolecules for their subsequent release (or the release of their associated products) has
brought a lot of interest in various biomedical research areas [166–169]. The incorporation of various
biomolecules (Table 2) into the hydrogel matrix without affecting their conformation and activity
is still challenging. Several strategies have been proposed for the encapsulation and attachment of
heat-sensitive and fragile biomolecules [170], their selection depending on the nature of the biomolecule
and the hydrogel structure, as presented below (Scheme 2).
Table 2. Summary of biomolecules entrapped within the matrix of hydrogels.
















Carbohydrates Covalent attachment,non-covalent attachment tissue regeneration [179,180]
Peptides Covalent attachment tissue adhesives,regeneration [181–184]
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Scheme 2. Schematic representation of the most common biomolecule immobilization approaches:
(a) non-covalent interaction; (b) covalent attachment, and (c) physical entrapment.
Three general approaches have been used in the last years for biomolecule immobilization:
covalent, non-covalent and physical entrapment. These approaches will be discussed below together
with their role in the release of specific cargo molecules.
4.1. Covalent Tethering of Biomolecules
The immobilization of biomolecules by formation of covalent bonds on a network is one of
the most widely used strategies because of the stable nature of the bonds formed between the hydrogel
matrix and the biomolecules, serving to retain the biomolecules. A variety of covalent linkages
have been explored for the attachment of biomolecules, including amide bonds formed through
carbodiimide chemistry, thiol-ene bonds and other covalent bonds formed through metal-free click
chemistry [185]. On the other hand, cleavable covalent linkages can be programmed to break over
time or in response to a stimuli, ranging from small-molecule bonds, such as ester bonds and disulfide
bonds, to macromolecular linkers, such as peptide and DNA sequences [186]. A special mention is
the use of disulfide bonds because, even though a stable covalent bond is formed between matrix
and biomolecules, this bond can be broken by the reaction with a suitable reducing agent, such as
tris(2-carboxyethyl)phosphine, under mild conditions. In addition, since the reactivity of the thiol
groups can be regulated by changing the pH, the yield of the methods involving disulfide bond
formation is usually high [187,188] Moreover, immobilization of biomolecules can be also achieved in
the pre-polymerization step: macromonomers can be composed of biomolecules. For example, four
armed-PEG was linked with CMP to form hydrogels by triple helical interactions [189]. NHS-terminated
PEG reacted with CMP either through single free amine at N-terminal or two free amines (one at
the N-terminal and other at side of chain of lysine). Triple helixes by intramolecular interactions between
CMPs at lower concentration and by intramolecular interactions between PEG-CMP conjugates at
higher concentration could form. In addition to triple helixes, CMPs also worked as cross-linkers,
leading to form chemically cross-linked network.
4.2. Supramolecular Tethering of Biomolecules
Several host-guest interactions make use of hydrophobic interactions for the attachment of
biomolecules as a key approach in supramolecular hydrogels because of its dynamic nature [190].
The principle of affinity between complementary biomolecules has also been extensively applied to
biomolecule bonding and release [191]. Macrocyclic oligosaccharides have an internal hydrophobic
pocket with which hydrophobic drugs can associate. In those systems, the drug release is primarily
controlled by the relative partitioning of solubilized drugs between the hydrogel and the release
medium, and is independent of the mesh size of the hydrogel [192,193]. The high selectivity due
to molecular recognition is a major advantage of host-guest interactions. Nevertheless, the use of
host-guest chemistry often requires the covalent binding of a costly affinity ligand (e.g., antibody or
aptamer) to the matrix [193]. Electrostatic interactions have been used to form strong non-covalent
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bonds between biomolecules and the polymer chains of the hydrogel [194]. The biomolecules
are released when the hydrogel is degraded or when the electrostatic interaction is screened by
the mobile ions from the environment. For example, a recombinant tissue inhibitor (rTIMP-3) was
electrostatically entrapped within the matrix of a biodegradable scaffold, whose cross-links are
degraded by metalloproteinase (MMP). When MMP attacks and digests the hydrogel cross-links,
the consequent disruption of the network lead to the gradual rTIMP-3 release [195].
4.3. Uncontrolled Release of Biomolecules from Hydrogel Networks
Typical mesh sizes reported for hydrogels range from 5 to 100 nm [196]. Because of the network
heterogeneity and polymer dispersity, hydrogels have a wide distribution of pore sizes within the same
network, which allows the entrapment, transport and release of a cargo. The entrapment method is
based on the retention of biomolecules within a hydrogel network that allows solvent molecules to pass
through its porous structure but retains the biomolecules of interest. In general, the diffusion-dominated
release of biomolecules cannot achieve over extended time points beyond a few hours to a day [197].
When the pore size approaches the biomolecule size, the effect of steric hindrance on biomolecules
diffusion becomes dominant and the release rate slows down. A very interesting example is the release
of GFs from hydrogels based on glycidyl methacrylated hyaluronic acid (HA-GM) and thiolated
heparin (Hep-SH) that were 3D-printed in a core-shell bilayer architecture [198]. The large pore
size of HA-GM-based hydrogels allowed free diffusion of the GF from the network. When heparin
was co-incorporated into the matrix of hydrogels, the release rate was significantly decreased due to
the electrostatic interactions between positively charged proteins (GFs) and the negatively charged
heparin. By adding an external shell of HA-GM/Hep-SH hydrogel, the rate of GF release was controlled.
If the pore size of the hydrogel is smaller than the biomolecule, this one remains entrapped inside of
the network unless the network degrades, the attachment of the biomolecule breaks or the pores size is
otherwise enlarged.
4.4. ‘On Demand’ Release of Biomolecules from Hydrogels Networks
The use of reversible methods to entrap biomolecules is highly attractive, mostly for economic
reasons simply because when the biomolecule activity decays the matrix support can be regenerated
and re-loaded with fresh biomolecules. For example, the reversible immobilization of enzymes is
especially relevant for immobilizing labile enzymes and for applications in bioanalytical systems [199].
Stimulus-responsive hydrogels have been especially useful, allowing for unprecedented levels
of control over material properties in response to an external stimulus, thus improving treatment of
many diseases and also improved approaches for tissue engineering and wound healing [200–202].
One strategy to control the release of biomolecules (or their products in the case of enzymes)
initially entrapped in a hydrogel is to regulate network degradation. Degradation can occur either
in the polymer backbone or at the cross-links. Some examples are the degradation mediated by
the binding of biomolecule of interest. It has been reported an aptamer-cross-linked hydrogel
trapped with glucoamylase [203]. Enzyme degradation is another important mechanism of action,
multi-responsive P(MAAc-co-NVP) bio-conjugated hydrogels were synthesized with biodegradable,
oligopeptide cross-links. This hydrogel was subject to enzyme-catalyzed degradation targeted by
trypsin, for the purpose of drug delivery to the small intestine [204]. An additional method to release
entrapped biomolecules consists in increasing the pore size by controlling the swelling of hydrogels.
Another strategy to achieve control over the release from hydrogels is to use stimuli-responsive
chemical bonds between the biomolecule and the polymer chains. This strategy is particularly relevant
for small biomolecules that have to be released, because they would otherwise be released within
a very short time period through spontaneous network diffusion (Figure 4) [205].
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Figure 4. (A) Designing microgels for loading and release of the model protein, cytochrome c
(cyt-c), by changing the distribution of ionizable groups into the microgel structure: N-pure PNIPAM
microgel; V-pure PVCL microgel; V−-anionic PVCL microgel; V±-PVCL polyampholyte microgel with
a random distribution of ionizable groups; V−N+-core−shell polyampholyte microgel consisting of
an anionic PVCL core (black network) and a cationic PNIPAM shell (grey network); (B) Schematic
representation of the protein loading and release into/from the polyampholyte microgels by reversibly
changing the hydrogel charges from positive to negative using the pH switch from acidic to basic;
(C) Effect of changing the pH value from 8 to 6, and respectively 3, on the amount of bound cyt-c for
the polyampholyte microgels comprising of V10−N10+ (a) and V10−5N10+ (b); Variation of the amount
of bound cyt-c vs. time at pH 3 for V10−N10+ and V10−5N10+ polyampholyte core-shell microgels in
comparison to the V20− polyelectrolyte microgels (c) [205].
Thus, this approach was used to modulate the release of a model protein, cytochrome c (cyt-c),
by controlling the content and distribution of acidic and basic moieties within the structure of
polyampholyte microgels. Considering the ability of these microgels to reversibly switch their
charges from positive to negative depending on the pH value, the microgel architecture was tuned
to obtain a core-shell structure with an anionic itaconic acid-based PVCL core (black network) and
a cationic PNIPAM shell (grey network) containing 1-vinylimidazole units. This shell acted as
an electrostatic potential barrier controlling the release of the protein (Figure 4). Several chemical
and physical interactions can be used alone or in combination, ranging from covalent conjugation
to supramolecular interactions, such as electrostatic interactions and hydrophobic associations [26].
Finally, also physical methods such as ultrasound have been used in hydrogels for drug delivery and
enhanced chemotherapy [206].
5. Biomolecules for Tissue Regeneration
Although easy-to-manipulate synthetic hydrogels have been prepared at a large scale for tissue
engineering applications, they act only as passive scaffolds [207]. These hydrogels specifically lack
from any specific bioactivities and do not support any cellular interactions [208,209]. Combination of
synthetic polymers with biomolecules, such as nucleic acids (DNA and RNA), protein, carbohydrate
and peptide, can be used to enhance the bioactivity of the resulted hydrogel matrix.
5.1. Nucleics Acids Conjugated to Synthetic Hydrogels
DNA and RNA are polynucleotides providing genetic information that can be delivered within
the cell and stimulate differentiation and growth, but they can be also a biopolymer that can be used
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as a substitute building block for hydrogel-based assemblies [210,211] Compared to the natural and
synthetic polymers, nucleic acids offer a high level of versatility and structural programmability
for many biomedical applications. Therefore, there are significant efforts to enlarge the domain
of nucleic acids-based hydrogels [31]. By attaching DNA to polymers as the side chain, DNAs
function as non-covalent cross-linkers in the hydrogel network and support the self-assembling
of the synthetic networks into second-order or higher-ordered structures in suitable environments,
leading to form multifunctional materials based on DNAs and non-natural polymers [171,212,213].
DNA-hydrogel assemblies can be formed with high mechanical strength, biocompatibility and
controllable morphologies while their functions, such as sequence designability, recognition ability,
responsiveness, and programmability can be easily adjusted by the choice of DNA and hydrogel [214].
DNA-linked hydrogels are a great alternative, to classically cross-linked gels for cell scaffolding [31,215].
Besides the removal of the generally toxic cross-linker, DNA gels resemble perfectly the ECM, and make
progressively space for cells to growth. Based on their composition, DNA-hydrogels are divided into
two groups; (i) pure DNA supramolecular hydrogels which are formed by branched and linear DNA
assembled matrixes depending on the design criteria and (ii) hybrid DNA supramolecular hydrogels
which employ synthetic polymers as backbone and DNAs as switchable cross-linking points [173].
Generally, DNA is attached covalently on the polymeric chain in order to function as a stable
cross-linking agent [126]. The covalent bond is generated by free-radical polymerization [216,217], click
chemistry [218], and thiol-ene chemistry [219]. Over all these reactions, click chemistry has been mainly
used since it is not only fast, specific and efficient [220], but also permits selective modification and
attachment of biologically active entities (e.g., adhesion or enzymatically degradable peptides) [221,222].
Besides chemical conjugation, noncovalent interactions (e.g., electrostatic interaction [223], hydrophobic
interactions [224], hydrogen bonds [225] and π−π interaction [226] between DNA and polymer) have
been employed (Scheme 3). The main advantages of hydrogels prepared by noncovalent interactions
are that they can form interconnected networks without need of toxic chemicals, bioactive molecules
can be easily entrapped, and they are biocompatible as medical biomaterials [174]. For example,
double-stranded DNAs were mixed with positively charged, water-soluble poly(phenylenevinylene) to
form a physical hydrogel [227]. Such system was proposed to track the drug release since the polymer
used made the hydrogel fluorescent.
Scheme 3. Schematics of DNA-functionalized hybrid hydrogels: (left) single-stranded DNA covalently
attached to the polymer scaffold, and (right) plasmids or long DNA sequences conjugated by
electrostatic interactions.
As the first example of hybrid DNA-hydrogels, the 5′-terminal-amino-modified
single stranded DNA (ssDNA) chains were conjugated with a P(DMAM-co-NAS) poly
(N,N-dimethylacrylamide-co-N-acryloyloxysuccinimide) through an active ester-amine click reaction.
Then ssDNAs were cross-linked with complementary DNA strands to form three-dimensional (3D)
polymer network [228]. Simply, individual ssDNAs were incorporated into polyacrylamide to obtain
either oligoT- or oligoA-polyacrylamide and then they cross-linked with each other to form hybrid
DNA-polyacrylamide hydrogels. In this hydrogel, DNA cross-linking was reversible depending on
the change of temperature, leading to use such system for bio sensing applications. Although DNA
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cross-linking has been mainly used for many of DNA-hydrogel systems, resulting assemblies suffer
from poor permeability of nutrients (e.g., larger proteins in size) due to the presence of small mesh in
hydrogel network [229]. This limits to use DNA-hydrogels in 3D cell culture and tissue engineering
applications. Besides being a functional cross-linker, DNA is also employed as a molecular information
carrier that sends growth impulses to the tissue. In order to deliver the information to the cells in
the damaged tissue and promote the healing of it, this has to enter the cell nucleus, and due to its size
and change the delivery is highly inefficient. There are few examples of efficient delivery, where DNA
is delivered under the form of a plasmid with and encoded GF [230].
Furthermore, RNAs in the form of short-interfering RNAs and microRNAs associated with
hydrogels have been successfully applied in the treatment of various diseases, in particular cancer and
infections [231]. Besides, the use of non-coding RNAs in molecular recognition and tissue engineering
has been also extended towards a new target, mainly the in vitro and in vivo tissue growth [232]. More
RNA-hydrogel based systems have been reviewed in more detail elsewhere [45,233,234].
5.2. Proteins Conjugated to Synthetic Networks
Recently, biocompatible and biodegradable protein hydrogels have been developed to be used
as functional biomaterials in the field of therapeutic delivery and tissue engineering. For example,
there are synthetic protein based hydrogels which are derived from single protein component such
as elastin [175], collagen [176], and globular proteins (e.g., bovine serum albumin, ovalbumin and
YajC-CT) [177,235]. The main advantages of pure protein hydrogels are relatively homogenous
network structure and simple procedure. However, often recombinant proteins are not only expensive
and difficult to produce at high amounts but also are not soluble in water and denatured during
the formation of protein hydrogels.
In protein-conjugated hydrogel networks, the proteins can be either cross-linkers, load-bearing
entities or molecular cues [181,236]. Cross-linker serve as a force transductor between different
protein chains whereas load-bearing entities regulate mechanical response of individual protein chains.
Depending on the cross-linking mechanism, the resulting hydrogels named as dynamic physical gels
and stable chemical (or covalent) gels [178,237–239]. The structure and properties of the primary chains
along with cross-linking density contribute to the chemical gels whereas molecular entanglement and
secondary molecular interactions play role in the formation of the physical gels. Physical gels are often
reversible and the interactions that hold physical gels can be disrupted by changes in environment
such as temperature, pH, ionic strength and so on. Besides, for hybrid protein-polymer hydrogels, load
bearing molecules are responsible for the deformation of the network and the hydrogel fracture occurs
due to breaking of cross-linkers [233]. When the hydrogel is cross-linked by specific ligand-receptor
complexation and global proteins serve as load-bearing molecules, the complex mechanical response
of hydrogel network is driven by both unfolding/refolding of global proteins and reversible bond
rupture/reformation of ligand-receptor complexation [181]. Thus, depending on the mechanical
properties of cross-linkers and load bearing molecules, the mechanical properties of hydrogel network
can be predicted. Towards this goal, three different hydrogels with predicted mechanical response have
been designed [178]. The hydrogels were composed of two components: (i) a multivalent cross-linker
(MCL), which consists of a four-armed PEG macromolecule fused with four Kir2.3 C-terminal tail
peptides (Kir), and (ii) ABA-type block proteins, which are composed of two Tax-interacting protein-1
(TIP-1) domains at the both ends of various proteins with distinct mechanical properties, namely GB1,
HP67, and SH3 respectively (Figure 5). The TIP-1 interacts with the Kir peptide forming a complex
with a high binding affinity, and this complexation acts as cross-linker (CL), whereas the center of
the ABA block protein is the load-bearing molecule (LBM). The mechanical properties of individual
cross-linker and load-bearing molecule were characterized by single-molecule force spectroscopy
and it was found out that the designed hydrogels exhibited the expected mechanical properties on
a molecular level. Then, synthetic protein hydrogels were prepared for mechanical testing in PBS at
RT (Figure 6). According to the stress-strain curves, Gel-1 was only extended by approximately 16%
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with Young’s modulus of about 150 kPa at a strain of 5% whereas Gel-2 was extended by 250% with
Young’s modulus of about 15 kPa at a strain of 50%, and Gel-3 was highly extensible with a failure
strain of ~215% and a Young’s modulus of ~27 kPa at a strain of 50%. These findings offer a framework
for construction of protein hydrogels with defined mechanical properties (e.g., elasticity, extensibility,
toughness and self-healing) for biomedical applications.
Figure 5. Design of hydrogel networks with mechanical properties similar to naturally occurring tissues:
(a) The hydrogel network is formed from two mechanical responsive elements: cross-linkers (CLs) and
load-bearing modules (LBMs). The binding/unbinding kinetics of the CL and the folding/unfolding of
the LBM are regulated by the applied mechanical force; (b) Structure of the protein domains (LBMs)
used in the hydrogel design to form the TIP-1:Kir complex: GB1, HP67, and SH3 [178]. The figure is
reproduced from an open access article published by Nature under a Creative Commons Attribution
4.0 International License (https://www.nature.com/articles/s41467-018-02917-6#rightslink).
Figure 6. Cont.
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Figure 6. The bulk mechanical properties of the designed hydrogels: (a) General procedure for
preparation of protein hydrogel rings for mechanical testing. All protein gels were cross-linked using
TIP-1:Kir complexes. (GB1)8, (GB1-HP67)4 and SH3 were used as the LBMs and the corresponding
hydrogels were denoted as Gel-1, Gel-2 and Gel-3, respectively; (b) Setup for the mechanical tests
of ring-shaped hydrogel. Stress-strain curves for the Gel-1, Gel-2 and Gel-3 until their breakage
(c–e). Representative stretching-relaxation curves for the Gel-1, Gel-2 and Gel-3 (f–h). The curves are
horizontally offset for clarity. The final strains are shown on the curves. Insets show the superposition
of the stretching-relaxation curves at different strains [178]. The figure is reproduced from an open
access article published by Nature under a Creative Commons Attribution 4.0 International License
(https://www.nature.com/articles/s41467-018-02917-6#rightslink).
Furthermore, to engineer protein-polymer hybrid hydrogels, cysteine residues have been used
to be cross-linked according to the thiol-Michael addition reactions (e.g., with electron-deficient
carbon-carbon double bonds or the free radical thiol-ene reaction via electron-rich/poor carbon-carbon
double bonds) [240,241]. Electron-deficient olefins for thiol-Michael addition reactions can be applied
for methacrylates, acrylates/acrylamides, vinyl sulfones, and maleimides [242]. However, these
reactions suffer from stability of cysteine residues without oxidation and slow reaction rate to create
homogenous hydrogels [243]. Besides, thiol-ene reactions have been combined with photo-initiated
free radical production, leading to spatiotemporally controllable hydrogel production [241,244].
Nevertheless, this type of reaction competes with homo-polymerization of enes and therefore hydrogel
production must be done in caution [245]. Additionally, genetically encodable click chemistries (e.g.,
SpyCatcher/tag, SNAP-tag, Snoop-tag, Halo-tag and CLIP-tag) have been applied to engineer protein
hydrogels [161,246–250]. For example, two peptide fragments derived from the CnaB2 domain of
Streptococcus pyogenes were covalently bound to each other via SpyCatcher/tag chemistry, resulting
to pure protein hydrogels [251]. In parallel with the development of multifunctional hydrogels
from polymer and recombinant proteins, functional proteins such as enzymes and antibodies have
been also incorporated into the polymer network. For example, calmodulin was incorporated either
into cross-linked polyacrylamide (PA) or PEG polymer networks, leading to calcium responsive
hydrogel [252,253]. Both hydrogel network underwent construction in the presence of calcium
ions and swell upon its chelation. There are also similar hydrogels that swell and contract due
to antigen-antibody binding and catalytic activity of grafted enzymes [254,255]. When the protein
becomes the bioactive element in the gel, then it transports an information towards the cell. Proteins
that carry information are generally zinc finger proteins (ZFPs), TALENS and monoclonal antibodies.
ZFPs and TALENS can recognize and bind DNA pairs, and block the expression of a gene. They
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are particularly useful to target cancer cells and silence them [256]. More used are mAB which bind
to an antigen to inactivate it or stimulate and immune response towards it [256]. Thus, instead of
promoting cell growth and regeneration, mAB are used to actively deplete the growth of a tissue,
for instance to fight the formation of excessive blood vessels in the retina, which leads to eyesight
loss. These mAB were encoded within in a synthetic self-assembled peptide gel, and depending on
the amount of gel present, the degree of vascularization could be inhibited accordingly (Figure 7) [257].
Figure 7. Histology of a self-assembled peptide hydrogel with mMA encoded within after 3 days (A,C)
and after 7 days (B,D). (C) and (D) show close to no cellular growth within the gel matrix [257].
Another way to deliver mAB is to tether them non-covalently on a hydrogel network, and tune
their release by introducing a competition molecule. This is the case for a poly(carboxybetaine)
hydrogel decorated with streptavidin molecules. These can bind the mAB, with however a lower
affinity strength as towards biotin. Once biotin was introduced, the mAB could be released, depending
on the biotin concentration, leading to a sustained release material [258].
Moreover, hydrogels can be also loaded with different GFs for promoting rapid skin tissue
regeneration and improve the angiogenesis, reepithelization, and neovascularization within
the damaged tissues [259]. For example, hydrogels have been loaded with different GFs, including
granule-lyophilised platelet rich fibrin [260], vascular endothelial GFs [260], collagen I [261], bone
morphogenic proteins [262], basic fibroblast GF [263]. More specifically, a PVA-based hydrogel was
loaded with granule-lypohilised platelet rich fibrin for treatment of skin wounds. PVA improved
the hydrogel biodegradability and mechanical properties whereas the GFs promoted faster rate of
wound healing with enhanced neovascularization and reepithelization. In addition, collagen I, known
to play a key role in smooth muscle formation and reepithelization of damaged skin, was conjugated
to various hydrogels with for soft tissue engineering applications [261].
5.3. Carbohydrates Conjugated to Synthetic Hydrogels
Carbohydrates, such as glycosaminoglycans (GAGs) and hyaluronic acid (HA), as components of
the ECM, are known for a wide range of biological functions. However, GAGs show chemical and
structural heterogeneity and are difficult to produce, which limits their use in hydrogel-based systems.
On the other hand, HA, with a simple and homogenous molecular structure composed of β-1,4-linked
d-glucuronic acid and β-1,3-N-acetyl-d-glucosamine disaccharide units, it is easy to produce [264].
Additionally, HA plays an important role in cellular adhesion, signaling differentiation, wound healing
and morphogenesis [179]. For example, ECMs based on hyaluronan derivatives and PEGDA were
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used to form covalently cross-linked and biodegradable 3D hydrogels for culture of primary and stem
cells in vitro and tissue formation in vivo [265]. In another example, valvular interstitial cells (VICs)
were encapsulated in enzymatically degradable and cross-linked 3D hydrogel cell culture platforms,
which were made by photo-initiated chain copolymerization of a methacrylate-containing HA with
a PEG cross-linker (Figure 8) [180]. Particularly, the increase of PEG content in hydrogels caused
a delay or prevented reverse gelation, while increasing the HA content led to a much faster degradation.
Moreover, the HA fragments released into the cell culture medium contributed to the manipulation of
the secretory properties of encapsulated VICs. The dual functionality shown by this bio-conjugated
hydrogel recommends it as a very promising material for heart valve tissue engineering.
Figure 8. (A) Multimethacrylated HA with m + n (m + n ≈ 10,000) repeat units (Mr ≈ 400 Da). In this
study, ~1 in 5 disaccharide units was functionalized with a methacrylate group. (B) Dimethacrylated
PEG chains with n repeat units (Mr ≈ 44, n ≈ 105) were end-capped with methacrylate groups.
(C) Hydrogel networks formed by radical initiated chain copolymerization of HA with varying
amounts of PEG. Primary radicals were produced by the dissociation of the photoinitiator,
1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propanone, in the presence of UV light
(l = 365 nm) [180].
5.4. Peptides Conjugated to Synthetic Hydrogels
Peptide-hydrogels are prepared by the self-assembly of oligopeptides into fibrous nanostructures
that generate gels due to cross-linking based on non-covalent interactions and entanglements (Scheme 4).
Typical pure peptide hydrogels are formed by supramolecular fibers of the β-sheet motifs
and gelation of α-helical coiled coils and collagen mimetic polyproline helices which have been
reviewed elsewhere [28,266–268]. Hybrid peptide-polymer hydrogels are formed by either direct
self-assembly of synthetic polymer chains conjugated with peptides or direct co-assembly with
polymers to produce supramolecular hydrogels [269]. PEG is very suitable as basis in the design of
hybrid peptide-polymer hydrogels because it enhances the circulation time of peptides when they
are conjugated to PEG [183,184]. One way to attach PEG to peptides is to utilize a multi-arm PEG to
lead to a network. Attachment of enzymatically degradable peptide brings biodegradability whereas
heparin-binding peptides provide biocompability [181,270]. Stiffness of resulting hydrogels were
in the range of physically cross-linked systems and thus PEG-CMP hydrogels can be used as soft
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substrates for cell-culture applications (Figure 9). In other examples, cysteine modified CMPs were
conjugated to multi-armed PEG through maleimide functional group [182]. Resulting hydrogels
showed thermo-responsive behavior and changeable mechanical properties depending on CMP length.
Besides, these hydrogels also exhibited honeycomb-like structure with pore size of 5–25 µm and used
as 3D environments for culture of human mesenchymal stem cells (hMSCs). The PEG was also used
to produce elastin-based hydrogels [183]. A peptide sequence (X(AKAAAKA)2X) was attached to
the azide functionalized polymer using copper(I) catalyzed azide-alkyne cycloaddition (aka click
reaction) and then hexamethylene diisocyanate was used to induce cross-linking and further gelation.
Several other polymers including PPO [183], PEODA [271], and HPMA [272], PNIPAM [273] have been
also applied as hydrogel scaffolds. Instead of only PEG, Pluronics (PEG PPO-PEG block copolymer)
were functionalized with peptide (AKAAAKA)2 and self-assembled into micelles and formed stable
viscoelastic hydrogels [183]. Besides, collagen mimetic peptide ((Pro-Hyp-Gly)7-Tyr) was coupled
to backbone of PEODA and resulting hydrogels were used as tissue engineering scaffolds [271]. In
another example, a linear copolymer was synthesized by radical copolymerization of HPMA and
the metal-chelating monomer DAMA [272]. Two histidine tagged peptides (Coiled Coil (CC) 1 peptide,
the amino acid region Val336-Ser590 from the Drosophila kinesin stalk protein and CC2 peptide, the de
novo designed coiled-coil sequence EK42) were separately mixed with the polymer in the presence
of nickel ions. Histidine-tagged CC peptides were formed complexes with iminodiacetate groups in
the presence of nickel ions, leading to form temperature responsive hybrid peptide-polymer hydrogels.
In another example of thermo-responsive hybrid hydrogels, PNIPAM has been conjugated with a short
ionic complementary peptide (FEFEFKFK) [273], the LLEELLEELEELLEEA (LE) peptide which forms
α-helix structure in the presence of calcium ions [273].
Co-assembled peptide-polymer hydrogels show high stability, tuneable mechanical properties,
better biofunctionality and develop new architectural versatility compared to the hybrid hydrogels
based on the self-assembly of peptide-conjugated polymers [274]. For example, low molecular weight
hydrogelator Na-fluorenylmethyloxycarbonyl diphenylalanine (Fmoc-FF) and hexapeptide based soft
hydrogelator PEG8-(FY)3 with three repetitions of the Phe-Tyr units and a N-terminus PEG moiety
was co-assembled to form biocompatible hydrogels [275]. Rheology analysis confirmed the improved
mechanical properties of co-assembled hybrid gels. Besides, the presence of PEG slowed down the gel
kinetic formation from 42 to 18 min and reduced the gel rigidity (reported as storage modulus, G’)
from 9 to 6 kPa, leading to be exogenous scaffold materials for tissue engineering applications. In
another example, peptide based co-assembled hydrogels consisted of two building blocks (Fmoc-FF
and Fmoc-arginine (Fmoc-R)), followed by incorporation of hydroxyapatite into the hydrogel matrix,
resulting into 3D hydrogel scaffolds for bone tissue regeneration [276].
Scheme 4. Schematic representation of peptide-functionalized hybrid hydrogels.
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Figure 9. (A) Fluorescence image of hMSC cells stained with Calcein, entrapped within the non-stained
gel matrix. (B) Cryo-SEM image of hMSC entrapped within the gel pores. (C) Scheme of hydrogel
formation via the reaction between an 8-arm maleimide functional PEG and a collagen triple helical
peptide [182].
6. Conclusions and Future Perspectives
The design of synthetic materials for regenerative medicine poses a series of challenges in terms of
biocompatibility, mechanical resistance and adaptability. The coupling of bio-inert polymer networks
with cell-active biomolecules requires the precise selection of hydrogel synthetic path and biomolecule
conjugation conditions to preserve their integrity and bioactivity. Hence, the interplay between
functionality and bioactivity relies on the careful choice of polymer structure, synthetic, production
path and specific biomolecule. Here, we addressed recent advances in conjugation of the most common
biomolecules (nucleic acids, proteins, short peptide sequences and carbohydrates) to functional
hydrogel soft-materials for regenerative medicine purposes. In addition, several applications of
bio-functionalized hydrogels were discussed, including the development of in vitro scaffolds, injectable
degradable scaffolds, wound healing, cartilage implants and gene delivery applications.
While numerous developments have been made so far in the area of bio-conjugated hydrogels
for biomedical applications, important challenges are still to be overcome. For example, further
improvements in the synthesis and structure of hydrogel matrices should be done to reduce the immune
response, and thus to minimize the inflammatory processes. Besides this, the exploitation of
multistimuli-responsive components would increase the functionality and versatility of bio-conjugated
hydrogel, widening their application range. The stimuli-responsive control over the stiffness of
hydrogels could be used to synthesize bio-material interfaces for the guided growth of cells and,
specifically, the differentiation of stem cells. Even though there is a plethora of examples of hydrogels
conjugated to single biomolecules, there are only few examples of hydrogels that contain multiple types
of biomolecules working together to serve the same purpose. In fact, integration of several biomolecules
into one hydrogel system could lead to the development of new materials in which cascade reactions
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can take place by integration of enzyme cofactors. As a consequence, these bio-materials are expected to
continuously draw a growing scientific and technological attention towards translational applications.
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